Quotes 5-day view End-of-day quote Korea Stock Exchange
10/26/2020
10/27/2020
10/28/2020
10/29/2020
10/30/2020
Date
59000
57900
60500
61200
59500
Last
281488
330125
220972
325758
321253
Volume
-2.32% -1.86% +4.49% +1.16% -2.78% Change
Sales 2020
1 588 B 1,40 B 1,40 B
Net income 2020
206 B 0,18 B 0,18 B
Net cash position 2020
503 B 0,44 B 0,44 B
P/E ratio 2020
18,7x
Yield 2020
0,66%
Sales 2021
1 646 B 1,45 B 1,45 B
Net income 2021
116 B 0,10 B 0,10 B
Net cash position 2021
572 B 0,50 B 0,50 B
P/E ratio 2021
33,4x
Yield 2021
0,69%
Capitalization
3 727 B 3 288 M 3 291 M
EV / Sales 2020
2 346x
EV / Sales 2021
2 264x
Nbr of Employees
1 546
Free-Float
73,0%
Yuhan Corporation is a Korea-based company mainly engaged in the manufacture and sale of pharmaceuticals. Along with its subsidiaries, the Company operates its business through three segments. The Pharmaceutical segment is engaged in the production and sale of non-prescription drugs including anti-inflammatory drugs, as well as prescription drugs such as drugs for hepatitis, diabetes, and hypertension. The Life and...
Notations Surperformance© of Yuhan Corporation
Trading Rating : Investor Rating :
All news about YUHAN CORPORATION
- No features available -
News in other languages on YUHAN CORPORATION
YUHAN CORPORATION - 05/08
The underlying trend is to the upside
BUY
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends YUHAN CORPORATION
Short Term Mid-Term Long Term Trends Bearish Neutral Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
16
Average target price
68 704,17 KRW
Last Close Price
59 500,00 KRW
Spread / Highest target
44,5%
Spread / Average Target
15,5%
Spread / Lowest Target
-14,8%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
